Kush Parmar, Director, 10% Owner at Entrada Therapeutics, Inc. (TRDA), sold 400,000 shares at $8.80 ($3.5M) on 2025-11-14, disclosed to the SEC on 2025-11-18.
Open-market sale of $3.5M TRDA by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.80 | 200,000 | $1.8M | 50.0% |
| 2 | $8.80 | 200,000 | $1.8M | 50.0% |
| Total | $8.80 avg | 400,000 | $3.5M | 100% |
| Filing → |
| TRDA | SELL | 2025-07-11 | $405K | — | Filing → |
| TRDA | SELL | 2025-07-01 | $1.6M | — | Filing → |
| SKYE | BUY | 2024-03-15 | $4.5M | — | Filing → |